DrugPatentWatch Database Preview

Ciclesonide - Generic Drug Details

« Back to Dashboard

What are the generic sources for ciclesonide and what is the scope of patent protection?

Ciclesonide is the generic ingredient in three branded drugs marketed by Covis Pharma Bv and is included in three NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ciclesonide has one hundred and fifty-six patent family members in forty-three countries.

There are seven drug master file entries for ciclesonide. Two suppliers are listed for this compound.

Summary for ciclesonide

International Patents:	156
US Patents:	5
Tradenames:	3
Applicants:	1
NDAs:	3
Drug Master File Entries:	7
Suppliers / Packagers:	2
Bulk Api Vendors:	44
Clinical Trials:	68
Patent Applications:	5,779
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for ciclesonide
DailyMed Link:	ciclesonide at DailyMed

See drug prices for ciclesonide

Recent Clinical Trials for ciclesonide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tehran University of Medical Sciences	Phase 3
Sunovion	Phase 1
National Heart, Lung, and Blood Institute (NHLBI)	Phase 3

See all ciclesonide clinical trials

Synonyms for ciclesonide

(11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione

(11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione

(11|A,16|A)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione

(R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate

126544-47-6

141845-82-1

2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-

2-oxoethyl isobutyrate

2H-Naphth (2',1':4,5) indeno (1,2-d) (1,3) dioxole, pregna-1,4-diene-3,20-dione deriv.

544C476

AC-1330

AC1MIWNR

AKOS015994702

Alvesco

Alvesco (TN)

Alvesco HFA

Alvesco, Ciclesonide

AN-15021

B-9207-015

BC220461

BTR-15

BTR-15K

BY-9010

BYK-20426

C-23151

C32H44O7

CAS-141845-82-1

CC-25775

CHEBI:31397

CHEMBL2040682

Ciclesonide (JAN/USAN/INN)

Ciclesonide [INN]

Ciclesonide [USAN:INN]

Ciclesonide, >=98% (HPLC)

Ciclesonide, European Pharmacopoeia (EP) Reference Standard

CS-2867

D01703

DB01410

DSSTox_CID_26659

DSSTox_GSID_46659

DSSTox_RID_81802

DTXSID9046659

el-87-6

GTPL7469

HMS3714N07

HY-B0625

KS-1165

LS-186047

LUKZNWIVRBCLON-GXOBDPJESA-N

MolPort-005-940-705

NCGC00167484-01

NCGC00167972-01

O945

Omnair

Omnaris

Omnaris (TN)

Omnaris HFA

Osonase

Osonide

Pregna-1,4-diene-3,20-dione, 16,17-(((R)-cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha)-

Pregna-1,4-diene-3,20-dione, 16,17-((cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha(R))-

RPR 251526

RPR-251526

RPR251526

s4646

S59502J185

SCHEMBL3688

SR-01000942227

SR-01000942227-1

TBN-15

Tox21_112486

UNII-S59502J185

Zetonna

ZINC3915154

Paragraph IV (Patent) Challenges for CICLESONIDE

Tradename	Dosage	Ingredient	NDA	Submissiondate
OMNARIS	SPRAY, METERED;NASAL	ciclesonide	022004	2012-02-13

US Patents and Regulatory Information for ciclesonide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Covis Pharma Bv	OMNARIS	ciclesonide	SPRAY, METERED;NASAL	022004-001	Oct 20, 2006		RX	Yes	Yes			Y
Covis Pharma Bv	ZETONNA	ciclesonide	AEROSOL, METERED;NASAL	202129-001	Jan 20, 2012		RX	Yes	Yes
Covis Pharma Bv	OMNARIS	ciclesonide	SPRAY, METERED;NASAL	022004-001	Oct 20, 2006		RX	Yes	Yes			Y
Covis Pharma Bv	OMNARIS	ciclesonide	SPRAY, METERED;NASAL	022004-001	Oct 20, 2006		RX	Yes	Yes			Y
Covis Pharma Bv	OMNARIS	ciclesonide	SPRAY, METERED;NASAL	022004-001	Oct 20, 2006		RX	Yes	Yes

Expired US Patents for ciclesonide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Covis Pharma Bv	ZETONNA	ciclesonide	AEROSOL, METERED;NASAL	202129-001	Jan 20, 2012
Covis Pharma Bv	ALVESCO	ciclesonide	AEROSOL, METERED;INHALATION	021658-003	Jan 10, 2008
Covis Pharma Bv	ZETONNA	ciclesonide	AEROSOL, METERED;NASAL	202129-001	Jan 20, 2012
Covis Pharma Bv	ALVESCO	ciclesonide	AEROSOL, METERED;INHALATION	021658-002	Jan 10, 2008
Covis Pharma Bv	OMNARIS	ciclesonide	SPRAY, METERED;NASAL	022004-001	Oct 20, 2006

International Patents for ciclesonide

Country	Patent Number	Estimated Expiration
Japan	4264211
Japan	4856338
Eurasian Patent Organization	200200375
Spain	2223595
Spain	2234681